Neuroleptics and Tardive Dyskinesia in Children
There’s an interesting February 11, 2014, article on Peter Breggin’s website: $1.5 Million Award in Child Tardive Dyskinesia Malpractice. (Thanks to Mad in America for the link.)
Here’s the opening paragraph:
“On February 11, 2014 a Chicago jury awarded $1.5 million to an autistic child who developed a severe case of tardive dyskinesia and tardive akathisia while being treated by psychiatrists with Risperdal and then Zyprexa between 2002 and 2007. The drug-induced disorder was diagnosed when he was fifteen years old and by then had become disabling and irreversible.”
Tardive dyskinesia is a movement disorder characterized by repetitive, involuntary movements, including: grimacing, tongue movements, chewing, lip smacking, puckering of the lips, purposeless limb and body movements, etc. . . The movements are sometimes described as Parkinsonian-like.
Tardive akathisia involves feelings of inner restlessness that can range from a mild sense of inner discomfort to an almost unbearable feeling of generalized tension. Victims of this condition can seldom sit still. They usually pace a great deal, sometimes for hours on end, and even when they sit or lie down, their limbs are in more or less constant motion.
Apparently the individual in Dr. Breggin’s paper was diagnosed with autism as a child and was prescribed SSRI’s before the age of seven. The SSRI’s caused some deterioration in the child’s behavior and mental condition, to combat which his first psychiatrist prescribed Risperdal (risperidone). Subsequently a second psychiatrist added Zyprexa (olanzapine) to the cocktail. Both Risperdal and Zyprexa are neuroleptics (euphemistically known in psychiatric circles as antipsychotics), and are known to cause tardive dyskinesia.
On the face of it, one would think that this would be a big story. One can picture the headline: “Psychiatrists Destroy Child’s Brain.” But in fact, the only references to this case that I’ve been able to find are the present article on Peter Breggin’s site, and links to Dr. Breggin’s article on Mad in America, Carl Elliott’s blog (Fear and Loathing in Bioethics), and Jon Rappoport’s Blog. Pharma’s stranglehold on the media is as effective as a government security blackout.
The truly tragic aspect of all this is that the neurotoxic effects of SSRI’s and neuroleptics are well known. It’s not like the thalidomide tragedy of the early 1960′s, in which the teratogenic effects weren’t known until it was too late. At which point, incidentally, the drug was taken off the market.
In the case of neuroleptics, or major tranquilizers as they used to be called, the link to tardive dyskinesia has been known for decades. In fact, Jean Delay and Pierre Deniker, French psychiatrists who are generally “credited” with introducing neuroleptics into psychiatry in the early 1950′s, promoted the notion that the dyskinesic effect was linked to the putative therapeutic effect. For this reason, they routinely raised the dose until this produced noticeable dyskinesia.
As the second generation neuroleptics became available, it was widely touted by pharma and by psychiatrists that these new drugs would not cause tardive dyskinesia. That claim is now discredited. The second generation neuroleptics do cause tardive dyskinesia, though perhaps at a slower rate than the earlier drugs. [CATIE Study]